183 related articles for article (PubMed ID: 11519864)
1. 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects.
Wang Q; Lee D; Sysounthone V; Chandraratna RAS ; Christakos S; Korah R; Wieder R
Breast Cancer Res Treat; 2001 May; 67(2):157-68. PubMed ID: 11519864
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
3. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
4. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
[TBL] [Abstract][Full Text] [Related]
5. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.
Danilenko M; Wang X; Studzinski GP
J Natl Cancer Inst; 2001 Aug; 93(16):1224-33. PubMed ID: 11504768
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
Narvaez CJ; Welsh J
Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
Eisman JA; Sutherland RL; McMenemy ML; Fragonas JC; Musgrove EA; Pang GY
J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
[TBL] [Abstract][Full Text] [Related]
9. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.
Simboli-Campbell M; Narvaez CJ; van Weelden K; Tenniswood M; Welsh J
Breast Cancer Res Treat; 1997 Jan; 42(1):31-41. PubMed ID: 9116316
[TBL] [Abstract][Full Text] [Related]
11. The role of vitamin D derivatives and retinoids in the differentiation of human leukaemia cells.
James SY; Williams MA; Kelsey SM; Newland AC; Colston KW
Biochem Pharmacol; 1997 Sep; 54(5):625-34. PubMed ID: 9337080
[TBL] [Abstract][Full Text] [Related]
12. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
[TBL] [Abstract][Full Text] [Related]
13. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
14. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
Abe J; Nakano T; Nishii Y; Matsumoto T; Ogata E; Ikeda K
Endocrinology; 1991 Aug; 129(2):832-7. PubMed ID: 1855478
[TBL] [Abstract][Full Text] [Related]
15. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
[TBL] [Abstract][Full Text] [Related]
16. Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced differentiation of HL-60 leukemia cells.
Kim SH; Kim SW; Choi SJ; Kim YC; Kim TS
Bioorg Med Chem; 2006 Oct; 14(19):6752-8. PubMed ID: 16765600
[TBL] [Abstract][Full Text] [Related]
17. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
Patel JB; Mehta J; Belosay A; Sabnis G; Khandelwal A; Brodie AM; Soprano DR; Njar VC
Br J Cancer; 2007 Apr; 96(8):1204-15. PubMed ID: 17387344
[TBL] [Abstract][Full Text] [Related]
18. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
Koga M; Eisman JA; Sutherland RL
Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of 1,25-dihydroxyvitamin D3 and retinoic acid in inducing U937 cell differentiation.
Tanaka Y; Shima M; Yamaoka K; Okada S; Seino Y
J Nutr Sci Vitaminol (Tokyo); 1992 Oct; 38(5):415-26. PubMed ID: 1284131
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
Campbell MJ; Reddy GS; Koeffler HP
J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]